{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:32:18Z","timestamp":1794591138501,"version":"4.9.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rmed.2026.109212","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:59:51Z","timestamp":1791907191000},"page":"109212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatable trait in COPD: is LVDD the potential next?"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9929-0073","authenticated-orcid":false,"given":"Pallav","family":"Bhattacharyya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0954-8286","authenticated-orcid":false,"given":"Sumedha","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-5315","authenticated-orcid":false,"given":"Parthasarathi","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.109212_bib1","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/COPD.S330817","article-title":"Treatable traits in COPD\u2013a proposed approach","volume":"18","author":"Cardoso","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2026.109212_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068034","article-title":"High prevalence of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: a cross-sectional study","volume":"8","author":"L\u00f3pez-S\u00e1nchez","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.rmed.2026.109212_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/medicina61071260","article-title":"Echocardiographic evidence of left ventricular dysfunction in COPD: relationship with disease severity","volume":"61","author":"Bhattacharjee","year":"2025","journal-title":"Medicina"},{"issue":"18","key":"10.1016\/j.rmed.2026.109212_bib4","first-page":"e876","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.rmed.2026.109212_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.echo.2025.03.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: an update from the American Society of Echocardiography","volume":"38","author":"Nagueh","year":"2025","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"16","key":"10.1016\/j.rmed.2026.109212_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.rmed.2026.109212_bib7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109212_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12933-018-0775-z","article-title":"Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure","volume":"17","author":"Soga","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109212_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5005\/jp-journals-11007-0216","article-title":"Does treatment of left ventricular diastolic dysfunction in chronic obstructive pulmonary disease matter: an appraisal from an open prospective real-world observation with use of dapagliflozin","volume":"68","author":"Bhattacharyya","year":"2026","journal-title":"Indian J. Chest Dis. Allied Sci."},{"issue":"21","key":"10.1016\/j.rmed.2026.109212_bib10","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.3390\/jcm13216509","article-title":"Clinical recommendations for managing genitourinary adverse effects in patients treated with SGLT-2 inhibitors: a multidisciplinary expert consensus","volume":"13","author":"Gorgojo-Mart\u00ednez","year":"2024","journal-title":"J. Clin. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:19:12Z","timestamp":1794590352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126005810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":10,"alternative-id":["S0954611126005810"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109212","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatable trait in COPD: is LVDD the potential next?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109212"}}